SCHEMBL460268

SCHEMBL460268

O=[N+]([O-])C(c1ccccc1)c1ccccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 6/20 0.53
SLC6A4 P31645 6/20 0.53
SLC6A3 Q01959 5/20 0.53
CHRM2 P08172 5/20 0.45
SCN1A P35498 3/20 0.45
SCN2A Q99250 3/20 0.45
SCN3A Q9NY46 3/20 0.45
ALDH1A1 P00352 4/20 0.44
CYP1A2 P05177 1/20 0.44
NPSR1 Q6W5P4 1/20 0.42
TSHR P16473 3/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 1/20 0.40
CNR1 P21554 1/20 0.40
KCNH2 Q12809 5/20 0.38
KCNA5 P22460 1/20 0.38
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10567133 0.78 LMNA (0.46) ALDH1A1NPSR1TSHRKDM4ELMNA
SCHEMBL30266801 0.77 SLC6A3 (0.45) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2
SCHEMBL1964629 0.77 CYP1A2 (0.42) ALDH1A1CYP1A2TSHRKDM4ELMNA
SCHEMBL3271045 0.76 SLC6A3 (0.54) SLC6A2SLC6A4SLC6A3ALDH1A1KDM4E
SCHEMBL10566039 0.74 NPSR1 (0.44) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2
SCHEMBL9092284 0.74 ALDH1A1 (0.43) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2
Bicarbonate SCHEMBL27706335 0.72 CES2 (0.46) ALDH1A1LMNACYP2D6L3MBTL1
SCHEMBL7053365 0.71 KDM4E (0.44) ALDH1A1CYP1A2NPSR1TSHRKDM4E
SCHEMBL17911851 0.71 ADRA2A (0.41) SLC6A2SLC6A4SLC6A3CHRM2SCN1A
SCHEMBL8119161 0.71 SLC6A3 (0.41) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3290021-A1 COMPOSTION FOR TOPICAL APPLICATION COMPRISING A PHOTOCHROMIC AGENT Unilever N.V. (NL) 2018-03-07 EP claimed
EP-1555009-B1 Skin make-up composition OREAL (FR) 2010-07-14 EP claimed
CN-100456398-C Electrolyte for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORP (JP) 2009-01-28 CN claimed
WO-2008078025-A2 MAKE-UP COMPOSITION FOR THE SKIN L'OREAL (FR) 2008-07-03 WO claimed
US-20070183992-A1 Cosmetic composition comprising porous particles incorporating optically active substances L'ORÉAL 2007-08-09 US claimed
US-20070029529-A1 Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor KOMATSU AKIHIKO 2007-02-08 US claimed
EP-1660024-A1 COSMETIC COMPOSITION COMPRISING POROUS PARTICLES INCORPORATING OPTICALLY ACTIVE SUBSTANCES L'OREAL (FR) 2006-05-31 EP claimed
US-20050175562-A1 crosslinked organopolysiloxane having dimethylvinylsiloxy end groups and a methylhydropolysiloxane having trimethylsiloxy end groups; water, oil, water soluble sovlent as liquid binder; and goniochromatic / photochromic or fluorescent coloring agents; cosmetic L'OREAL S.A. (FR) 2005-08-11 US claimed
EP-1555009-A1 Skin make-up composition L'OREAL (FR) 2005-07-20 EP claimed
WO-2005011622-A1 COSMETIC COMPOSITION COMPRISING POROUS PARTICLES INCORPORATING OPTICALLY ACTIVE SUBSTANCES L'OREAL (FR) 2005-02-10 WO claimed
US-20040245105-A1 Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORPORATION (JP) 2004-12-09 US claimed
CN-1529892-A Electrolyte for driving electrolytic capacitor and electrolytic capacitor 如碧空株式会社 2004-09-15 CN claimed
EP-1437749-A1 ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR Rubycon Corporation (JP) 2004-07-14 EP claimed
EP-0970689-B1 Make-up product with a photochromic pigment and a UV-filter and its uses OREAL (FR) 2002-09-18 EP claimed
US-6080415-A SEPARATE PACKAGES OF A FIRST COMPONENT OF A COSMETIC MEDIUM CONTAINING A PHOTOCHROMIC COLORING AGENT WHICH PRODUCES A COLOR IN THE PRESENCE OF ULTRAVIOLET RADIATION AND THE SECOND A SUNSCREENING AGENT; IMPROVED COLORANT EFFECT; PATTERNS L'OREAL (FR) 2000-06-27 US claimed
EP-0970689-A2 Make-up product with a photochromic pigment and a UV-filter and its uses L'OREAL (FR) 2000-01-12 EP claimed
EP-0060723-B2 INDICATOR FOR DETECTING ETHYLENE OXIDE EKIKA CARBON DIOXIDE CO. LTD. (JP) 1989-11-15 EP claimed
EP-0060723-B1 INDICATOR FOR DETECTING ETHYLENE OXIDE EKIKA CARBON DIOXIDE CO. LTD. (JP) 1985-07-10 EP claimed
CN-122070121-A Hair dye composition 宝洁公司 2026-05-19 CN disclosed
US-4081275-A Photographic film units containing colorless para-nitrobenzylidene dye-forming compounds EASTMAN KODAK COMPANY (US) 1978-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050175562-A1 crosslinked organopolysiloxane having dimethylvinylsiloxy end groups and a methylhydropolysiloxane having trimethylsiloxy end groups; water, oil, water soluble sovlent as liquid binder; and goniochromatic / photochromic or fluorescent coloring agents; cosmetic MICA, MITF, CUTA SLC6A2 4163/4885SLC6A4 3077/4885SLC6A3 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.